The FDA-approved smoking cessation pill, varenicline, offers a promising pathway for teens and young adults looking to break free from the grips of nicotine addiction, particularly from vaping.Recent research from Mass General Brigham highlights that participants aged 16 to 25 who took this twice-daily medication were over three times more successful in quitting vaping than those who relied solely on behavioral counseling.